Four Swiss-based companies will received state funding to develop a range of new drugs to treat coronavirus, which are expected to be available by the end of 2022.
This content was published on
1 minute
swissinfo.ch/dos
Português
pt
Governo suíço financia quatro novos medicamentos contra a Covid
The contracts were signed in the context of the Federal Funding Programme for Covid-19 Medicines, run by the Federal Office for Public Health (FOPH) and the Swiss Innovation Agency Innosuisse, the government said on MondayExternal link.
The total value of the four deals is CHF27 million ($29.2 million).
The projects aim to treat a range of the symptoms caused by a Covid-19 infection and to mitigate the length and severity of illness.
Two of the drugs are monoclonal antibody treatments: one for the neuropsychiatric symptoms in sufferers of long Covid, and the other for use on patients at risk of a severe course of Covid-19. A third project is developing an oral pulmonary vasodilator which makers hope will prevent respiratory failure and reduce the need for artificial ventilation.
A final project is an antiviral and anti-inflammatory to treat “all severities of Covid-19”.
Switzerland will enjoy “certain benefits” in return for its investment, the government stated. This includes having a first option on purchases of the drugs.
The government’s medical procurement capabilities to tackle the coronavirus pandemic come under the remit of the Covid-19 law, approved for a second time by voters in a nationwide referendum two weeks ago.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
Viola Amherd has expressed her “deep shock” at the assassination attempt on Slovakian Prime Minister Robert Fico on Wednesday.
This content was published on
A man injured half a dozen people with knives, two of them seriously, before being arrested on Wednesday in northern Switzerland.
Switzerland to introduce flight passenger database
This content was published on
Switzerland plans to introduce a flight passenger database to collect and process personal data in a bid to combat terrorism and serious crime.
Government plans to invest over CHF16bn in Swiss rail network
This content was published on
The federal government intends to invest CHF16.4 billion ($18.1 billion) in railway infrastructure between 2025 and 2028, CHF2 billion more than for the current period.
Swiss to vote on pension reform and biodiversity in September
This content was published on
Swiss citizens will vote on occupational pension schemes and a biodiversity initiative on September 22, the Federal Council announced on Wednesday.
Ukraine peace talks: 50 countries have confirmed participation
This content was published on
To date, 50 countries out 160 invited delegations have confirmed they will attend the Ukraine peace conference, held in central Switzerland in mid-June, according to Swiss public radio, RTS.
Federer-backed On boosts forecast after sneaker demand rises
This content was published on
Swiss footwear company On Holding AG posted strong first-quarter revenue, boosted by demand for its running shoes and new line of training apparel.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
It’s not all about age: why Covid hits some people harder than others
This content was published on
New insights: two studies involving Swiss scientists suggest genes and blood sugar levels play a crucial role in the course of Covid-19.
This content was published on
Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.